Las Glucogenosis en España: Situación Actual y Guías Informativas

Current Neurology and Neuroscience Reports; 7(1): 71-77.

[3] Von Baethmann M, Sträub V y A Reuser (2009) "Pompe disease", Pharmazie

in unserer Zeit; 38 (1): 97.

|4] Van der Ploeg y A Reuser (2008) " Pompe's disease", Lancet; 372 (9646):

1342-1343.

|5| McKusick VA ed. (2004) Online mendelian inheritance in man (OMIM). Bal-

timore. The Johns Hopkins University. Entry n" 232300

(6| Chien YH et al (2008) "Early detection of Pompe disease by newborn screen-

ing is feasible: results from the Taiwan screening program", Pediatrics; 122 (1):
e39-45.

|7| Kroos et al (2008) "Update of the Pompe disease mutation database with 107

sequence variants and a format of severity rating", Human Mutations; 29 (6): E13-
26.

[8| Pittis MG et al (2008) "Molecular and functional characterization of eight

novel GAA mutations in Italian infants with Pompe disease", Human Mutations;
29 (6): E27-36.
[9] Wan Let al (2008) "Identification of eight novel mutations of the acid alpha-
glucosidase gene causing the infantile or juvenile form of glycogen storage disease
type \\" Journal of Neurology; 255 (6): 831-838.

[ 10] Engel A y R Hirschhorn (1994) "Metabolic disorders affecting muscle: acid

maltase deficiency", en Engel, A y C Franzini-Armstrong eds. Myology: Basic
and clinical. 2^nd ed. New York. McGraw-Hill; pp. 1533-1551.

[11] Van den Houe H et al (2003) "The natural course of infantile Pompe disease:

20 original cases compared with 133 cases from the literature", Pediatrics; 112 (2):
332-340.

153

Las Glucogenosis en España

[12] Nicolino M et al (2004) "Natural history of infantile onset Pompe disease

(IOPD): Results from a retrospective chart review study." Proceedings of the 2004
Annual Symposium on Lysosomal Storage Disorders.

[13] Marsden D (2005) "Infantile onset Pompe disease: a report of physician nar-

ratives from an epidemiologie study", Genetics in Medicine; 7 (2): 147-150.

[ 14| Kishnani PS et al (2006) "A retrospective, multinational, multicenter study on

the natural history of infantile-onset Pompe disease", Journal of Pediatrics; 148
(5): 671-676.

[15] Fayssoil A (2008) "Cardiomyopathy in Pompe's disease", European Journal

of Internal Medicine; 19 (1): 57-59.

[ 16] Slonim AE et al (2000) "Identification of two subtypes of infantile acid mal-

tase deficiency". Journal of Pediatrics; 137 (2): 283-285.

[ 17] Winkel LP et al (2005) "The natural course of non-classic Pompe's disease;

a review of 225 published cases", Journal of Neurology; 252 (8): 875-884

[ 18] Hagemans ML et al (2005) "Clinical manifestation and natural course of late-

onset Pompe's disease in 54 Dutch patients", Brain; 128 (Pt 3): 671-677.

[ I9| Hagemans ML et al (2005) "Disease severity in children and adults with

Pompe disease related to age and disease duration", Neurology; 64 (12): 2139-
2141.

1201 Wokke JH et al (2008) "Clinical features of late-onset Pompe disease: a

prospective cohort study", Muscle and Nerve; 38 (4): 1236-1245.

[21] Van der Beek NA et al A (2008) "Rate of disease progression during long-term

follow-up of patients with late-onset Pompe disease", Neuromuscular Disorders;
en prensa.

[22] Mellies U y F Lofaso (2009) " Pompe disease: a neuromuscular disease with

respiratory muscle involvement", Respiratory Medicine; en prensa.

[23] Mellies U et al (2001) "Sleep-disordered breathing and respiratory failure in

acid maltase deficiency", Neurology; 57:1290-1295.

[24] Retai D et al (2008) "Thrombotic complications of a basilar artery aneurysm

in a young adult with Pompe disease", Surgical Neurology; 70 (5): 518-520.

154

Las Glucogenosis en España

[25] Brettschneider J et al (2008) "Intracerebral hemorrage in a patient with

glycogenosis type II (Pompe disease): is there a pathophysiological relationship?",